Whole-Exome Sequencing Identifies Homozygous Mutations in a Spastic Ataxia-Neuropathy Syndrome Linked to Mitochondrial -AAA Proteases

English version České info

We report an early onset spastic ataxia-neuropathy syndrome in two brothers of a consanguineous family characterized clinically by lower extremity spasticity, peripheral neuropathy, ptosis, oculomotor apraxia, dystonia, cerebellar atrophy, and progressive myoclonic epilepsy. Whole-exome sequencing identified a homozygous missense mutation (c.1847G>A; p.Y616C) in AFG3L2, encoding a subunit of an m-AAA protease. m-AAA proteases reside in the mitochondrial inner membrane and are responsible for removal of damaged or misfolded proteins and proteolytic activation of essential mitochondrial proteins. AFG3L2 forms either a homo-oligomeric isoenzyme or a hetero-oligomeric complex with paraplegin, a homologous protein mutated in hereditary spastic paraplegia type 7 (SPG7). Heterozygous loss-of-function mutations in AFG3L2 cause autosomal-dominant spinocerebellar ataxia type 28 (SCA28), a disorder whose phenotype is strikingly different from that of our patients. As defined in yeast complementation assays, the AFG3L2^Y616C gene product is a hypomorphic variant that exhibited oligomerization defects in yeast as well as in patient fibroblasts. Specifically, the formation of AFG3L2^Y616C complexes was impaired, both with itself and to a greater extent with paraplegin. This produced an early-onset clinical syndrome that combines the severe phenotypes of SPG7 and SCA28, in additional to other “mitochondrial” features such as oculomotor apraxia, extrapyramidal dysfunction, and myoclonic epilepsy. These findings expand the phenotype associated with AFG3L2 mutations and suggest that AFG3L2-related disease should be considered in the differential diagnosis of spastic ataxias.

Vyšlo v časopise: Whole-Exome Sequencing Identifies Homozygous Mutations in a Spastic Ataxia-Neuropathy Syndrome Linked to Mitochondrial -AAA Proteases. PLoS Genet 7(10): e32767. doi:10.1371/journal.pgen.1002325
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002325

Souhrn

Zdroje

1. MalteccaFAghaieASchroederDGCassinaLTaylorBA 2008 The mitochondrial protease AFG3L2 is essential for axonal development. J Neurosci 28 2827 2836

2. Di BellaDLazzaroFBruscoAPlumariMBattagliaG 2010 Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nat Genet 42 313 321

3. TatsutaTLangerT 2008 Quality control of mitochondria: protection against neurodegeneration and ageing. EMBO J 27 306 314

4. CagnoliCStevaninGBrussinoABarberisMManciniC 2010 Missense mutations in the AFG3L2 proteolytic domain account for approximately 1.5% of European autosomal dominant cerebellar ataxias. Hum Mutat 31 1117 1124

5. EdenerUWollnerJHehrUKohlZSchillingS 2010 Early onset and slow progression of SCA28, a rare dominant ataxia in a large four-generation family with a novel AFG3L2 mutation. Eur J Hum Genet 18 965 968

6. CasariGDe FuscoMCiarmatoriSZevianiMMoraM 1998 Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93 973 983

7. AtorinoLSilvestriLKoppenMCassinaLBallabioA 2003 Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia. J Cell Biol 163 777 787

8. FerreirinhaFQuattriniAPirozziMValsecchiVDinaG 2004 Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J Clin Invest 113 231 242

9. MalteccaFMagnoniRCerriFCoxGAQuattriniA 2009 Haploinsufficiency of AFG3L2, the gene responsible for spinocerebellar ataxia type 28, causes mitochondria-mediated Purkinje cell dark degeneration. J Neurosci 29 9244 9254

10. MartinelliPLa MattinaVBernacchiaAMagnoniRCerriF 2009 Genetic interaction between the m-AAA protease isoenzymes reveals novel roles in cerebellar degeneration. Hum Mol Genet 18 2001 2013

11. ChoiMSchollUIJiWLiuTTikhonovaIR 2009 Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci U S A 106 19096 19101

12. NgSBBuckinghamKJLeeCBighamAWTaborHK 2010 Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 42 30 35

13. JohnstonJJTeerJKCherukuriPFHansenNFLoftusSK 2010 Massively parallel sequencing of exons on the X chromosome identifies RBM10 as the gene that causes a syndromic form of cleft palate. Am J Hum Genet 86 743 748

14. MoolenaarSHPoggi-BachJEngelkeUFCorstiaensenJMHeerschapA 1999 Defect in dimethylglycine dehydrogenase, a new inborn error of metabolism: NMR spectroscopy study. Clin Chem 45 459 464

15. BinzakBAWeversRAMoolenaarSHLeeYMHwuWL 2001 Cloning of dimethylglycine dehydrogenase and a new human inborn error of metabolism, dimethylglycine dehydrogenase deficiency. Am J Hum Genet 68 839 847

16. Marchler-BauerAAndersonJBChitsazFDerbyshireMKDeWeese-ScottC 2009 CDD: specific functional annotation with the Conserved Domain Database. Nucleic Acids Res 37 D205 210

17. BonnFPantakaniKShoukierMLangerTMannanAU 2010 Functional evaluation of paraplegin mutations by a yeast complementation assay. Hum Mutat 31 617 621

18. NoldenMEhsesSKoppenMBernacchiaARugarliEI 2005 The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria. Cell 123 277 289

19. KoppenMMetodievMDCasariGRugarliEILangerT 2007 Variable and tissue-specific subunit composition of mitochondrial m-AAA protease complexes linked to hereditary spastic paraplegia. Mol Cell Biol 27 758 767

20. LeeSAugustinSTatsutaTGerdesFLangerT 2011 Electron cryomicroscopy structure of a membrane-anchored mitochondrial AAA protease. J Biol Chem 286 4404 4411

21. AugustinSGerdesFLeeSTsaiFTLangerT 2009 An intersubunit signaling network coordinates ATP hydrolysis by m-AAA proteases. Mol Cell 35 574 585

22. CagnoliCMariottiCTaroniFSeriMBrussinoA 2006 SCA28, a novel form of autosomal dominant cerebellar ataxia on chromosome 18p11.22-q11.2. Brain 129 235 242

23. McFarlandRTaylorRWTurnbullDM 2010 A neurological perspective on mitochondrial disease. Lancet Neurol 9 829 840

24. NasirJFrimaNPickardBMalloyMPZhanL 2006 Unbalanced whole arm translocation resulting in loss of 18p in dystonia. Mov Disord 21 859 863

25. KremmidiotisGGardnerAESettasatianCSavoiaASutherlandGR 2001 Molecular and functional analyses of the human and mouse genes encoding AFG3L1, a mitochondrial metalloprotease homologous to the human spastic paraplegia protein. Genomics 76 58 65

26. GnirkeAMelnikovAMaguireJRogovPLeProustEM 2009 Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol 27 182 189

27. BentleyDRBalasubramanianSSwerdlowHPSmithGPMiltonJ 2008 Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456 53 59

28. Wood-AllumCShawPJ 2010 Motor neurone disease: a practical update on diagnosis and management. Clin Med 10 252 258

29. NgSBTurnerEHRobertsonPDFlygareSDBighamAW 2009 Targeted capture and massively parallel sequencing of 12 human exomes. Nature 461 272 276

30. KoppenMLangerT 2007 Protein degradation within mitochondria: versatile activities of AAA proteases and other peptidases. Crit Rev Biochem Mol Biol 42 221 242

31. TatsutaTAugustinSNoldenMFriedrichsBLangerT 2007 m-AAA protease-driven membrane dislocation allows intramembrane cleavage by rhomboid in mitochondria. EMBO J 26 325 335

32. WittigISchaggerH 2008 Structural organization of mitochondrial ATP synthase. Biochim Biophys Acta 1777 592 598

33. KlementPNijtmansLGVan den BogertCHoustekJ 1995 Analysis of oxidative phosphorylation complexes in cultured human fibroblasts and amniocytes by blue-native-electrophoresis using mitoplasts isolated with the help of digitonin. Anal Biochem 231 218 224